Search academic texts

Information × Registration Number 0304U001007, 0102U003051 , R & D reports Title To study a prevalence and main resistance mechanism of nosocomial pneumonia pathogens and to work out the optimal schemes of antibacterial chemotherapy of this group of patients popup.stage_title Розробити оптимальні режими антибактеріальної терапії хворих на нозокоміальну пневмонію на основі виявлених механізмів резистентності збудників захворювання Head Dzyublyk Olexander Yaroslavovich, Registration Date 12-01-2004 Organization Institute of tuberculosis and pulmonology named by F. G. Yanovsky popup.description2 Regimens empirical antibacterial therapies were developed for nosocomial pneumonia (NP) patients, which appeared in intensive care department for cardiology (cyprofloxacin and ceftriaxon/tobramycin) and surgical (amikacin and ceftazidimum or cyprofloxacin) clinics. Their using allows to reach the improvements at 81,8% patients with NP and reduce mortality validity. The application sphere - pulmonology Product Description popup.authors popup.nrat_date 2020-04-02 Close